Skip to Content, Navigation, or Footer.
Sunday, Dec. 14, 2025
The Daily Pennsylvanian

10-03-20 Penn Medicine (Max Mester).jpg

At Penn, NIH funding has supported work on CAR T-cell therapy, mRNA technology, rare disease treatments, and cancer therapies. Max Mester

At Penn, NIH funding has supported work on CAR T-cell therapy, mRNA technology, rare disease treatments, and cancer therapies.